Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.0B | 2.7B | 1.8B | 1.8B |
| Cost of revenue | 1.2B | 1.3B | 1.1B | 962M |
| Gross profit | 807M | 1.4B | 641M | 840M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 370M | 925M | 243M | 437M |
| Non operating interest income | ||||
| Income | 10M | — | 5M | 9M |
| Expense | 249M | 255M | 243M | 246M |
| Other income expense | 14M | 50M | -31M | -186M |
| Pretax income | 145M | 720M | -26M | 14M |
| Tax provision | -9M | 119M | -199M | -9M |
| Net income | 154M | 601M | 173M | 23M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 726M | 1.3B | 572M | 783M |
| Net income from continuing op. | 154M | 601M | 173M | 23M |
| Minority interests | — | — | 0 | -1M |
| Preferred stock dividends | — | — | — | — |